A Double‐blind, Randomized, Multicenter Phase 3 Study of Palonosetron vs Granisetron Combined With Dexamethasone and Fosaprepitant to Prevent Chemotherapy‐induced Nausea and Vomiting in Patients With Breast Cancer Receiving Anthracycline and Cyclophosphamide

Cancer Medicine - United Kingdom
doi 10.1002/cam4.2979
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer: A Prospective Cohort Study

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2019English

Efficacy of Triple Antiemetic Therapy (Palonosetron, Dexamethasone, Aprepitant) for Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Carboplatin-Based, Moderately Emetogenic Chemotherapy.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Fixed Combination of Oral NEPA (Netupitant‐palonosetron) for the Prevention of Acute and Delayed Chemotherapy‐induced Nausea and Vomiting in Patients Receiving Multiple Cycles of Chemotherapy: Efficacy Data From 2 Randomized, Double‐blind Phase III Studies

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Ramosetron Versus Palonosetron in Combination With Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Cannabinoids for Nausea and Vomiting in Adults With Cancer Receiving Chemotherapy

Cochrane Database of Systematic Reviews
2015English

Granisetron Transdermal System in the Management of Chemotherapy-Induced Nausea and Vomiting

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2016English

A Comparison of Intravenous Ondansetron and Palonosetron in Preventing Post-Operative Nausea and Vomiting After Laparoscopic Cholecystectomy - A Randomized Double-Blind Study

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: Approval and Efficacy

Cancer Management and Research
Oncology
2009English

Daily Palonosetron Is Superior to Ondansetron in the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients With Acute Myelogenous Leukemia

Cancer
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy